← Leaderboards
Yue Sun
Virginia Commonwealth University
$2,061,283
Attributed
$2,061,283
Total exposure
2
Grants
2
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $368.7K · FY2017–24$500K$375K$250K$125K$0
'17
'18
'19
'20
'21
'22
'23
'24
Funding mix
By agency
NIH$2,061,283 · 2
By mechanism
R01$1,832,533 · 1
R03$228,750 · 1
Top collaborators
No co-investigators on record.
Most similar at Virginia Commonwealth University
Same institution · by research overlap
- Larisa Litovchick$3,327,925
- Fatmata Sesay$111,940
- Rene Olivares-Navarrete$2,348,517
- Bin Gao$700,617
Others in their field
Other Emerging Leaders on “Pathway Interactions”
- April Brinkoetter · Hungry Heart Media, Inc.$59,802,265
- Kevin Urdahl · Seattle Children'S Hospital$47,227,116
- Urs Ochsner · Crestone, Inc.$38,569,476
- Mathangi Thiagarajan · Leidos Biomedical Research, Inc.$37,695,154
- Nader Fotouhi · Global Alliance For Tb Drug Development$28,468,137
- Jeffrey Glenn · Stanford University$26,017,226
Research focus
Pathway InteractionsPublic Health RelevanceLinkNovel StrategiesPhosphatidylinositol PhosphatesPhosphotransferasesIn VitroLaboratoriesMalignant NeoplasmsNeoplasm MetastasisGrowthPhosphatidylinositol 4,5-DiphosphateCell LinePhosphatidylinositolsHead And Neck Squamous Cell CarcinomaCell ProliferationIn VivoKnockout MiceEventLysosomesEpidermal Growth Factor ReceptorMouse ModelDown-RegulationReceptor Protein-Tyrosine Kinases
Grant awards (7)
PIPKIgammai5 in the Control of HNSCC Progression$361,344
R01 · FY2024 · DE · contact PI
PIPKIgammai5 in the Control of HNSCC Progression$368,719
R01 · FY2023 · DE · contact PI
PIPKIgammai5 in the Control of HNSCC Progression$365,032
R01 · FY2022 · DE · contact PI
PIPKIgammai5 in the Control of HNSCC Progression$368,719
R01 · FY2021 · DE · contact PI
PIPKIgammai5 in the Control of HNSCC Progression$368,719
R01 · FY2020 · DE · contact PI
A Novel Phosphoinositide-regulated Pathway in Mig6 Expression and HNSCC Response to Anti-EGFR Therapy$114,375
R03 · FY2018 · DE · contact PI
A Novel Phosphoinositide-regulated Pathway in Mig6 Expression and HNSCC Response to Anti-EGFR Therapy$114,375
R03 · FY2017 · DE · contact PI